news Mitochondria repair in mice may provide answers on Parkinson’s disease 4 August 2021 | By Anna Begley (Drug Target Review) Researchers used an experimental small molecule that helped restore the removal of damaged mitochondria from brain cells in a mouse model of Parkinson's.
news Potential COVID-19 antivirals revealed in large-scale drug analysis 5 July 2021 | By Anna Begley (Drug Target Review) Drug analysis at the Francis Crick Institute and University of Dundee has revealed 15 potential antivirals that could lead to new COVID-19 treatments.
news New screening hub to identify COVID-19 drugs funded in Scotland 8 January 2021 | By Victoria Rees (Drug Target Review) LifeArc and the Medical Research Council have funded a new drug screening facility that will be established to accelerate COVID-19 drug discovery.
news £4 million in funding announced to collect data on COVID-19 antibodies 19 November 2020 | By Victoria Rees (Drug Target Review) UKRI will provide £4 million in funding to establish a data infrastructure for scientists in the UK to study antibodies from COVID-19 patient samples.
news CBD molecule has potential to treat rare skin diseases, study shows 17 November 2020 | By Victoria Rees (Drug Target Review) Researchers have found that CBD induces an enzyme with antioxidant and anti-inflammatory properties in the top layer of the skin.
news UK government to invest £8.4 million into COVID-19 immunology research 1 September 2020 | By Victoria Rees (Drug Target Review) The UK government will invest £8.4 million in COVID-19 research projects to reveal more information that can be used to develop therapies and vaccines against the disease.
news Parkinson’s inhibitor enzyme presents natural therapeutic opportunity 1 November 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered an enzyme that blocks a genetic pathway that causes Parkinson’s, which could be used as a treatment in the future.
news New insights into the origins of mutations in cancer 2 May 2018 | By Drug Target Review Scientists use data from human cancers and C. elegans to understand mutational causes of cancer...
news Scientists discover promising off-switch for inflammation 30 March 2018 | By Dr Zara Kassam (Drug Target Review) Scientists have discovered that itaconate - a molecule derived from glucose - acts as a powerful off-switch for macrophages...
news ‘Molecular commando’ identified to tackle hypoxic response 4 November 2016 | By Niamh Louise Marriott, Digital Content Producer Researchers used pioneering techniques to develop a `small molecule’ chemical probe which offers highly targeted access to the hypoxic signalling pathway...
news Newly discovered protein may hold key to better drugs for neglected diseases 3 November 2016 | By Niamh Louise Marriott, Digital Content Producer Bicyclic nitro-drugs used in the treatment of tuberculosis, including the recently approved drug delamanid, were reported as promising fast track options...
news Study of gene mutations improves understanding of inherited Parkinson’s disease 29 July 2016 | By Mandy Parrett, Editorial Assistant Scientists have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson’s disease.
news TB drug could also target visceral leishmaniasis 24 May 2016 | By Victoria White, Digital Content Producer Delamanid could also be a powerful tool to combat visceral leishmaniasis researchers at the University of Dundee have found...
news Collaboration to develop new treatments for tuberculosis 8 March 2016 | By Victoria White Scientists at the Universities of Dundee and Cape Town are teaming up with Bayer to develop critically needed new treatments for tuberculosis...
